Envestnet Asset Management
DERM icon

Envestnet Asset Management’s Journey Medical DERM Stock Holding History

Envestnet Asset Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Buy
71,636
+38,042
+113% +$295K ﹤0.01% 4209
2025
Q4 		$259K Sell
33,594
-27,356
-45% -$214K ﹤0.01% 4127
2025
Q3 		$434K Sell
60,950
-9,041
-13% -$65.6K ﹤0.01% 3864
2025
Q2 		$503K Sell
69,991
-33,162
-32% -$229K ﹤0.01% 3681
2025
Q1 		$609K Sell
103,153
-404
-0.4% -$1.99K ﹤0.01% 3500
2024
Q4 		$405K Sell
103,557
-6,029
-6% -$32.9K ﹤0.01% 3707
2024
Q3 		$619K Sell
109,586
-21,985
-17% -$113K ﹤0.01% 3414
2024
Q2 		$742K Buy
131,571
+102,596
+354% +$422K ﹤0.01% 3217
2024
Q1 		$107K Buy
+28,975
New +$126K ﹤0.01% 4053

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Envestnet Asset Management's DERM Position: Q1 2026 in Review

Envestnet Asset Management increased its Journey Medical (DERM) stake by 113% in Q1 2026, buying an estimated $295K and bringing the position to 71,636 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #4209.

Envestnet Asset Management first reported a position in DERM in Q1 2024 and has held it in 9 quarters since. The position peaked at $742K in Q2 2024. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Envestnet Asset Management held 71,636 shares of Journey Medical worth $336K as of Q1 2026.
  • Envestnet Asset Management bought 38,042 Journey Medical shares in Q1 2026, an estimated $295K.
  • Journey Medical made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #4209 holding.
  • Envestnet Asset Management first reported a position in Journey Medical in Q1 2024 and has held it in 9 quarters since.
  • Envestnet Asset Management's Journey Medical position peaked at $742K in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.